Edit

Fund+

https://www.fundplus.be
Last activity: 10.01.2024
Invests in categories: DevelopmentBioTechTechnologyWebsiteDrugPlatformProductResearchMedtechHealthTech
News
66
Portfolio
20
Persons
3
Mentions
8
Location: Belgium, Flemish Brabant, Tienen
Employees: 11-50
Investment Type: Venture Capital
Investment Stage: Series B; Series C

Portfolio 20

DateNameWebsiteTotal RaisedLocation
29.08.2022AstriVaxastrivax.c...$32.62MBelgium, F...
07.06.2022Minoryx Th...minoryx.co...$106.01MSpain, Cat...
09.11.2017Horamahorama.fr$22.17MFrance, Il...
-Indigo Dia...indigomed....$44.72MBelgium, E...
-TargEDtargedbiop...$44.28MNetherland...
-Aelin Ther...aelintx.co...-Belgium, F...
-Cardiorcardior.de$167.11MGermany, L...
-Ona Therap...ona-therap...$35.46MSpain, Cat...
-Immunic AGimmunic-th...--
-Octimetoctimet.co...-Belgium, A...
Show more

Persons 3

DateFirst NameLast NameTitleLinkedInLocation
-HalinaNovakPrinciplelinkedin.c...-
-MarkWaerHonorary C...linkedin.c...-
-LucDebruyneChairman o...-

News 66

DateTitleDescription
30.08.2023Confo Therapeutics Appoints Dieter Weinand, Former CEO of Ba...Ghent, Belgium – August 29, 2023 – Confo Therapeutics, a leader in the discovery of medicines target...
15.06.2023Confo Therapeutics Enters into Research Collaboration for GP...• Collaboration to make use of Confo’s unique suite of ConfoBody®-enabled antibody discovery technol...
05.06.2023ONA Therapeutics Announces the Appointment of Dr Pamela Klei...• Leading medical oncologist and seasoned biotechnology executive with significant experience in dru...
05.06.2023Coave Therapeutics announces Positive 12-months Data from On...– CTx-PDE6b demonstrated clinically meaningful benefit in visual functions at the highest dose and e...
05.06.2023Minoryx gains FDA approval to initiate a Phase 3 clinical tr...US trial with leriglitazone to commence in mid-2023 providing an FDA-approved route to US market whi...
15.05.2023Indigo Appoints Dr. Arun Venkatasubramanian as Chief Technol...Arun is an award-winning engineer who brings over 15 years’ experience in leading the design and dev...
25.04.2023Minoryx presents positive interim results from NEXUS registr...Initial evidence of disease stabilization was demonstrated for all patients using radiological, clin...
20.04.2023Tubulis Announces Strategic License Agreement with Bristol M...MUNICH, GERMANY, April 20, 2023 – Tubulis and Bristol Myers Squibb (NYSE: BMY) today announced that ...
30.03.2023Confo Therapeutics Enters into Collaboration Agreement with ...Ghent, Belgium – March 30, 2023 – Confo Therapeutics, a leader in the discovery of medicines targeti...
13.03.2023ExeVir Bio and VIB Announce Data on a New Therapy for Preven...Ghent, Belgium, 13 March 2023: ExeVir Bio, a biotech company developing robust single domain antibod...
Show more

Mentions in press and media 8

DateTitleDescriptionSource
31.05.2022Minoryx Therapeutics closes €51M Series C round co-led by Co...31/05/2022 Press release YSIOS CAPITAL JOINS ITS PORTFOLIO COMPANY. MINORYX THERAPEUTICS, €51 MILL...webcapital...
03.05.2022Tubulis Closes €60 Million Series B Financing to Accelerate ...May 3, 2022htgf.de/en...
22.02.2022TargED Biopharmaceuticals raises EUR 39 Million in Series A ...TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking throm...hadeanvent...
16.06.2020Alta Life Sciences invests in Ona Therapeutic’s €30M Series ...Barcelona, Spain, June 16th 2020: Ona Therapeutics, which is focused on the discovery and developmen...altals.com...
26.09.2018Minoryx Therapeutics raises €21.3M in Series B funding round...Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, to...caixacapit...
26.09.2018Minoryx cierra una ronda Serie B de €21,3M liderada por Fund...26/09/2018 Nota de prensa MINORYX CIERRA UNA RONDA SERIE B DE €21,3 MILLONES LIDERADA POR FUND+, A...webcapital...
05.09.2017Immunic Therapeutics gewinnt zwei weitere Investoren und kom...Planegg-Martinsried, 5. September 2017: Immunic AG (Immunic Therapeutics), ein junges Biotechnologie...bmp.com/de...
-Egle Therapeutics raises 40 million € Series A to develop Fi...LSP and Bpifrance, through its InnoBio 2 Fund, co-led international investor syndicatebioqubeven...

Reviews 0

Sign up to leave a review

Sign up Log In